Insider · CIK 0001673852
Novartis Institutes for BioMedical Research, Inc.
Files at: NTLA, SURF, QTTB. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2018 JForm 5 → | Feb 14, 2019, 4:02 pm EST | Intellia Therapeutics, Inc.NTLA | 75,222 | — | — | 4,352,295 | — | plan? |
| Apr 23, 2018 PForm 4 → | Apr 23, 4:43 pm EDT | Surface Oncology, Inc.SURF | 766,666 | $15.00 | $11,499,990 | 3,948,482 | +24.1% | plan? |
| Apr 23, 2018 CForm 4 → | Apr 23, 4:43 pm EDT | Surface Oncology, Inc.SURF | 3,181,816 | — | — | 3,181,816 | — | plan? |
| Apr 2, 2018 CForm 4 → | Apr 4, 4:24 pm EDT | Homology Medicines, Inc.FIXX | 1,979,226 | — | — | 1,979,226 | — | plan? |
| Dec 12, 2017 SForm 4 → | Dec 14, 12:19 pm EST | Intellia Therapeutics, Inc.NTLA | 1,523,000 | $18.30 | $27,870,900 | 4,129,903 | −26.9% | plan? |
| Mar 3, 2017 JForm 4 → | Mar 7, 3:11 pm EST | Intellia Therapeutics, Inc.NTLA | 79,245 | — | — | 5,652,903 | — | plan? |
| May 11, 2016 PForm 4 → | May 11, 6:57 pm EDT | Intellia Therapeutics, Inc.NTLA | 277,777 | $18.00 | $4,999,986 | 5,573,658 | +5.25% | plan? |
| May 11, 2016 CForm 4 → | May 11, 6:57 pm EDT | Intellia Therapeutics, Inc.NTLA | 5,295,881 | — | — | 5,295,881 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2018 CForm 4 → | Apr 23, 4:43 pm EDT | Surface Oncology, Inc.SURF | 6,785,715 | — | — | 0 | — | |
| Apr 2, 2018 CForm 4 → | Apr 4, 4:24 pm EDT | Homology Medicines, Inc.FIXX | 1,979,226 | — | — | 0 | — | |
| May 11, 2016 CForm 4 → | May 11, 6:57 pm EDT | Intellia Therapeutics, Inc.NTLA | 8,190,476 | — | — | 0 | — |